Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00610402 · ClinicalTrials.gov registry record
Incidence of Ocular Antibodies in Patients With Sturge - Weber Syndrome (SWS)
A clinical trial, sponsored by University of California, Irvine.
- Completed
- Registry status
- 57
- Enrollment target
NCT00610402 is a clinical trial that has completed, run by University of California, Irvine. The registered enrollment target is 57 participants.
The verdict
NCT00610402 has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- 57 participants
- Enrollment target
Study Summary
Sturge-Weber Syndrome (SWS) is a neurological disorder characterized at birth by seizures and a large port-wine stain birthmark on the forehead and upper eyelid of one side of the face. SWS is also accompanied by an increased pressure within the eye (glaucoma) which can develop very early in life. Glaucoma represents a group of ocular disorders that are characterized by the loss of retinal ganglion cells and their axons, damage to the optic nerve, and gradual loss of visual field. Recently, several studies provided evidence that there is a potential role of the immune system in the pathogenesis of glaucoma. These findings suggest that there might be changes in systemic humoral immunity possibly underlying the optic neuropathy in at least some glaucoma patients.
Interventions
- OTHER blood sample tear drop sample
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2007-07 |
| Est. Completion | 2008-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00610402
The ClinicalTrials.gov registry entry for NCT00610402 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which blood sample tear drop sample is the first listed.
NCT00610402 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00610402 about?
NCT00610402 is a clinical study titled "Incidence of Ocular Antibodies in Patients With Sturge - Weber Syndrome (SWS)". Sturge-Weber Syndrome (SWS) is a neurological disorder characterized at birth by seizures and a large port-wine stain birthmark on the forehead and upper eyelid of one side of the face. SWS is also accompanied by an increased pressure within the eye (glaucoma) which can develop very early in life. ...
What is the current status of trial NCT00610402?
This trial is currently completed. The enrollment target is 57 participants. The study started on 2007-07. Estimated completion is 2008-06.
What interventions are being tested in trial NCT00610402?
The interventions under investigation include: blood sample tear drop sample (OTHER).
Who is sponsoring clinical trial NCT00610402?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.